Results 211 to 220 of about 427,464 (325)
Liraglutide for idiopathic intracranial hypertension: a real‐world propensity score‐matched study
Annals of Clinical and Translational Neurology, Volume 12, Issue 4, Page 746-755, April 2025.Abstract Objective Idiopathic intracranial hypertension (IIH) is a neurological disorder predominantly affecting young women with obesity, characterized by elevated intracranial pressure. While current treatments include weight loss counseling, medical therapies, and surgical interventions, their limitations necessitate exploring novel therapeutic ...
Ahmed Y. Azzam +13 more
wiley +1 more source
An MRI assessment of mechanisms underlying lesion growth and shrinkage in multiple sclerosis
Annals of Clinical and Translational Neurology, Volume 12, Issue 4, Page 686-700, April 2025.By applying the tensor model, we analysed lesion orientation and the directionality of lesion expansion/contraction in multiple sclerosis. Each lesion is summarized as an ellipsoid, and the tensor model is applied to calculate lesion anisotropy. From the top to the bottom white matter atlas, surface‐in gradient segmentation and venous atlas used in the
Ermelinda De Meo +9 more
wiley +1 more source
CELSIOR®, A NEW ORGAN PRESERVATION SOLUTION, IN KIDNEY AND PANCREAS EXPERIMENTAL TRANSPLANTATION.
, 2000 Nicola Baldan +6 more
openalex +1 more source
Annals of Clinical and Translational Neurology, Volume 12, Issue 3, Page 615-630, March 2025.This study aimed to assess gray matter (GM) atrophy, the contribution of white matter (WM) lesions, and consequent structural disconnectivity in minority patients with multiple sclerosis (PwMS). Minority PwMS were found to have greater lesion burden and GM atrophy. Differences in GM atrophy were partially mediated by WM pathology. Abstract Objective To
Ahmed Bayoumi +8 more
wiley +1 more source
Amifostine enhances the antioxidant and hepatoprotective effects of UW and HTK preservation solutions. [PDF]
World J Gastroenterol, 2014 Akbulut S +6 more
europepmc +1 more source
Amygdala Neurodegeneration: A Key Driver of Visual Dysfunction in Parkinson's Disease
Annals of Clinical and Translational Neurology, Volume 12, Issue 4, Page 768-779, April 2025.ABSTRACT Objective Visual disability in Parkinson's disease (PD) is not fully explained by retinal neurodegeneration. We aimed to delineate the brain substrate of visual dysfunction in PD and its association with retinal thickness. Methods Forty‐two PD patients and 29 controls underwent 3‐Tesla MRI, retinal spectral‐domain optical coherence tomography,
Asier Erramuzpe +15 more
wiley +1 more source
Preservation solutions for cardiac and pulmonary donor grafts: a review of the current literature. [PDF]
J Thorac Dis, 2014 Latchana N +3 more
europepmc +1 more source